NRC Group’s 5-Year CEO Option Grant: A Delayed Payday Amid a 27% Shareholder Selloff

The Board just handed out a massive, long-dated paycheck. In a move that reads more like deferred compensation than immediate skin in the game, it granted 1.6 million share options to senior executives under its long-term incentive program. The CEO, Anders Gustafsson, received the largest slice: 550,000 share options. The strike price is set at NOK 7.90, which is well above the stock's recent trading levels. The catch? These options cannot be exercised until at least 1 April 2028. That's a gain that remains a distant, non-tradeable future event for the CEO.

This timing raises an immediate red flag. The grant comes as the stock has been under severe pressure. Shares have declined 27.2% since the company reported its earnings for the quarter ended Dec. 31, 2025. That's a brutal drop that has crushed shareholder value. In this context, a large grant of options exercisable years from now looks less like a bet on near-term performance and more like a promise of a future payout, regardless of the current pain.

The alignment of interest here is deeply questionable. For the CEO to truly have skin in the game, his potential gain should be tied to the stock's recovery and growth in the near term. Instead, the Board has locked in a distant payday. This structure does little to incentivize the CEO to fix the problems that are driving the stock down today. It's a classic case of smart money (the Board) rewarding itself with a long-dated option, while the public shareholders are left holding the bag as the stock languishes.

The Financial Context: Weak Results and a Skeptical Market

The grant of 1.6 million share options arrives against a backdrop of weak operational results and a market that is clearly not buying the optimism. For the full year 2025, NRC Group reported an EBIT margin of just 2.1%, a thin profit on a revenue base of 6.6 billion NOK. The company's own commentary frames this as a "financial and operational foundation" being strengthened, but the numbers tell a story of grinding pressure. The guidance for 2026 calls for an operating margin above 3.0%, a modest improvement that suggests management sees a path to better profitability. The market's reaction is one of deep skepticism. Since the Q4 earnings report in late February, shares have declined 27.2%. That's a brutal drop that has left the stock down 22% over the past month alone, a stark underperformance against a flat broader market. This isn't a reaction to a single bad quarter; it's a sustained sell-off that discounts the company's forward-looking guidance. The smart money is looking past the promised margin expansion and focusing on the reality of a thin 2.1% profit margin and a 5% revenue decline in the last quarter.

The disconnect between management's confident tone and the stock's violent reaction is the core tension. CEO Anders Gustafsson called 2025 a year of "improved margins" and a "clear growth agenda," while the Board just handed him a massive, long-dated option grant. The market, however, is saying the current financials don't justify that level of optimism. When a company's stock is getting crushed on weak results, a large grant of options exercisable years from now looks less like a bet on a turnaround and more like a delayed paycheck for the executives who presided over the decline. The skin in the game is purely deferred.

Smart Money vs. Insider Pay: What to Watch

The Board's grant is a future obligation, not a current bet. True skin in the game comes from executives buying shares on the open market, not from receiving options exercisable years from now. The recent grant to CEO Anders Gustafsson and other top brass is a promise of compensation, not a signal of confidence in the stock's near-term rebound. For now, the real smart money is looking elsewhere.

The company's own 2025 annual report provides a sliver of positive data: the order backlog improved to NOK 9.2 billion. That's a tangible backlog of work that strengthens future revenue visibility, which is a key metric for institutional investors. It's the kind of fundamental detail that can attract long-term capital if the stock finds a floor.

So, what's the real play here? The key watchpoint is institutional positioning. Are the 13F holders-those who file quarterly with the SEC-accumulating shares ahead of the 2028 exercise window, seeing value in that backlog? Or are they selling into the weakness, echoing the market's deep skepticism? The grant itself does nothing to answer that. It's a distraction from the real signal: the flow of money from professional investors. Until we see evidence of institutional accumulation, the smart money's verdict remains unclear. The skin in the game is still in the future, and the whales are waiting to see if the water warms.